Karnail S. Atwal

4.6k citations

69 papers · 3.9k indexed · 3 hit papers · h-index 28

Organic Chemistry top 0.5%
Molecular Biology top 10%
Pharmacology top 2%
Pathology and Forensic Medicine top 5%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Brian C. O'Reilly Suzanne Moreland Anders Hedberg George C. Rovnyak Joseph E. Schwartz David Floyd Jack Z. Gougoutas Mary F. Malley
Topics: Cardiac electrophysiology and arrhythmias (14 papers)Ion channel regulation and function (14 papers)Cardiac Ischemia and Reperfusion (11 papers)
Cited by: Organic Chemistry Pharmacology Toxicology
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry American Journal of Physiology-Heart and Circulatory Physiology
Partner nations: United States Germany Sweden

In The Last Decade

Karnail S. Atwal

69 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents

1991 721 citations Karnail S. Atwal, Brian N. Swanson et al. Journal of Medicinal Chemistry profile →
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents

1992 400 citations George C. Rovnyak, Karnail S. Atwal et al. Journal of Medicinal Chemistry profile →
Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

1990 342 citations Karnail S. Atwal, George C. Rovnyak et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Karnail S. Atwal

Since Specialization

Citations

This map shows the geographic impact of Karnail S. Atwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karnail S. Atwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karnail S. Atwal more than expected).

Fields of papers citing papers by Karnail S. Atwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karnail S. Atwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karnail S. Atwal. The network helps show where Karnail S. Atwal may publish in the future.

Co-authorship network of co-authors of Karnail S. Atwal

This figure shows the co-authorship network connecting the top 25 collaborators of Karnail S. Atwal. A scholar is included among the top collaborators of Karnail S. Atwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karnail S. Atwal. Karnail S. Atwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Heather J. Finlay,Ji Jiang,(unknown),(unknown),Mary Lee Conder,(unknown),Paul Lévesque,(unknown),(unknown),Karnail S. Atwal,Michael A. Blanar,Ruth R. Wexler,John Lloyd	9
2	Triphenylphosphine Oxide Is a Potent and Selective Inhibitor of the Transient Receptor Potential Melastatin-5 Ion Channel 2010 ·Assay and Drug Development Technologies ·R. Kyle Palmer,Karnail S. Atwal,(unknown),(unknown),(unknown),Rok Cerne,(unknown),(unknown),(unknown),Aaron C. Pawlyk,(unknown),Dennis Sprous,Zheng Zhang,Robert W. Bryant	60
3	Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Jing Zhang,Mengxiao Shi,Stephen P. O’Connor,(unknown),Chi Li,Doree Sitkoff,Andrew T. Pudzianowski,Saeho Chong,Herbert E. Klei,Kevin Kish,Joseph Yanchunas,Eddie C.‐K. Liu,Karen S. Hartl,(unknown),Thomas E. Steinbacher,William A. Schumacher,Karnail S. Atwal,Philip D. Stein	13
4	Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·John Lloyd,Heather J. Finlay,Karnail S. Atwal,(unknown),(unknown),Lin Yan,(unknown),Wayne Vaccaro,Tram Huynh,Christine Huang,(unknown),Tonya Jenkins-West,Huabin Sun,Danshi Li,Paul Lévesque	35
5	Synthesis and evaluation of acylguanidine FXa inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Stephen P. O’Connor,Karnail S. Atwal,Chi Li,Eddie C.‐K. Liu,Steven M. Seiler,Mengxiao Shi,Yan Shi,Philip D. Stein,Ying Wang	7
6	Dihydropyrazolopyrimidine Inhibitors of KV1.5 (IKur) 2008 ·Bioorganic & Medicinal Chemistry Letters ·Wayne Vaccaro,Tram Huynh,John Lloyd,Karnail S. Atwal,Heather J. Finlay,Paul Lévesque,Mary Lee Conder,Tonya Jenkins-West,Hong Shi,Lucy Sun	24
7	Benzopyran sulfonamides as KV1.5 potassium channel blockers 2007 ·Bioorganic & Medicinal Chemistry Letters ·John Lloyd,Karnail S. Atwal,Heather J. Finlay,(unknown),Tram Huynh,(unknown),(unknown),(unknown),Wayne Vaccaro,Mary Lee Conder,Tonya Jenkins-West,Paul Lévesque	27
8	Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Doree Sitkoff,Jing Zhang,Wei Han,Zilun Hu,Philip D. Stein,Ying Wang,Lawrence J. Kennedy,Stephen P. O’Connor,(unknown),Eddie C.‐K. Liu,(unknown),Patrick Y. S. Lam,Jeffrey A. Robl,John E. Macor,Karnail S. Atwal,Robert Zahler	9
9	Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Karnail S. Atwal,Steven V. O’Neil,Saleem Ahmad,(unknown),Mark Kirby,Charles R. Dorso,Gamini Chandrasena,Bang‐Chi Chen,Rui-Lin Zhao,Robert Zahler	33
10	Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase 2005 ·Bioorganic & Medicinal Chemistry Letters ·David S. Weinstein,Wen Liu,Zhengxiang Gu,Charles M. Langevine,Khehyong Ngu,(unknown),Donald W. Combs,Doree Sitkoff,(unknown),Shaobin Zhuang,Xing Chen,(unknown),Deborah A. Loughney,Karnail S. Atwal,Robert Zahler,John E. Macor,Cort S. Madsen,Natesan Murugesan	46
11	N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Karnail S. Atwal,Saleem Ahmad,Charles Z. Ding,Philip D. Stein,John Lloyd,Lawrence G. Hamann,David W. Green,(unknown),(unknown),W. Lynn Rogers,(unknown),Arthur V. Miller,(unknown),(unknown),Ling Li,K. J. Yost,(unknown),Cort S. Madsen	12
12	Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1 2003 ·Bioorganic & Medicinal Chemistry Letters ·Saleem Ahmad,Khehyong Ngu,Donald W. Combs,Shung Wu,David S. Weinstein,Wen Liu,Bang‐Chi Chen,Gamini Chandrasena,Charles R. Dorso,Mark Kirby,Karnail S. Atwal	18
13	Pharmacologic Profile of the Selective Mitochondrial‐K_ATPOpener BMS‐191095 for Treatment of Acute Myocardial Ischemia 2002 ·Cardiovascular Drug Reviews ·Gary J. Grover,Karnail S. Atwal	23
14	Cardioselective Anti-Ischemic ATP-Sensitive Potassium Channel Openers. 3. Structure-Activity Studies on Benzopyranyl Cyanoguanidines; Modification of the Cyanoguanidine Portion 1995 ·Journal of Medicinal Chemistry ·Karnail S. Atwal,Gary J. Grover,Syed Z. Ahmed,Paul G. Sleph,Steven Dzwonczyk,(unknown),Diane E. Normandin	17
15	Cardioprotective Profile of the Cardiac-Selective ATP-Sensitive Potassium Channel Opener BMS-180448 1995 ·Journal of Cardiovascular Pharmacology ·Gary J. Grover,John R. McCullough,Albert J. DʼAlonzo,Carol A. Sargent,Karnail S. Atwal	60
16	Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agentsbreakdown → 1992 ·Journal of Medicinal Chemistry ·George C. Rovnyak,Karnail S. Atwal,Anders Hedberg,S. David Kimball,Suzanne Moreland,Jack Z. Gougoutas,Brian C. O'Reilly,Joseph E. Schwartz,Mary F. Malley	400
17	Dihydropyrimidine angiotensin II receptor antagonists 1992 ·Journal of Medicinal Chemistry ·Karnail S. Atwal,Syed Z. Ahmed,J. Eileen Bird,Carol L. Delaney,Kenneth E.J. Dickinson,(unknown),Anders Hedberg,Arthur V. Miller,Suzanne Moreland	30
18	Modulation of potassium channels by organic molecules 1992 ·Medicinal Research Reviews ·Karnail S. Atwal	44
19	Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines 1990 ·Journal of Medicinal Chemistry ·Karnail S. Atwal,George C. Rovnyak,Joseph E. Schwartz,Suzanne Moreland,Anders Hedberg,Jack Z. Gougoutas,Mary F. Malley,David Floyd	242
20	Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesbreakdown → 1990 ·Journal of Medicinal Chemistry ·Karnail S. Atwal,George C. Rovnyak,S. David Kimball,David Floyd,Suzanne Moreland,Brian N. Swanson,Jack Z. Gougoutas,Joseph E. Schwartz,(unknown),Mary F. Malley	342

About Karnail S. Atwal

Karnail S. Atwal is a scholar working on Organic Chemistry, Cardiology and Cardiovascular Medicine and Emergency Medicine, having authored 69 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (14 papers) and Cardiac Ischemia and Reperfusion (11 papers). The work is most often cited by research in Organic Chemistry (3.0k citations), Pharmacology (440 citations) and Toxicology (68 citations). Karnail S. Atwal has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Brian C. O'Reilly, Suzanne Moreland, Anders Hedberg, George C. Rovnyak, Joseph E. Schwartz, David Floyd, Jack Z. Gougoutas, Mary F. Malley, Brian N. Swanson and S. David Kimball. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact